Antigen Information
General Information of This Antigen
| Antigen ID | TAR0UJYSQ |
|||||
|---|---|---|---|---|---|---|
| Antigen Name | Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1) |
|||||
| Gene Name | ENTPD1 |
|||||
| Synonym | CD39 |
|||||
| Sequence |
MEDTKESNVKTFCSKNILAILGFSSIIAVIALLAVGLTQNKALPENVKYGIVLDAGSSHT
SLYIYKWPAEKENDTGVVHQVEECRVKGPGISKFVQKVNEIGIYLTDCMERAREVIPRSQ HQETPVYLGATAGMRLLRMESEELADRVLDVVERSLSNYPFDFQGARIITGQEEGAYGWI TINYLLGKFSQKTRWFSIVPYETNNQETFGALDLGGASTQVTFVPQNQTIESPDNALQFR LYGKDYNVYTHSFLCYGKDQALWQKLAKDIQVASNEILRDPCFHPGYKKVVNVSDLYKTP CTKRFEMTLPFQQFEIQGIGNYQQCHQSILELFNTSYCPYSQCAFNGIFLPPLQGDFGAF SAFYFVMKFLNLTSEKVSQEKVTEMMKKFCAQPWEEIKTSYAGVKEKYLSEYCFSGTYIL SLLLQGYHFTADSWEHIHFIGKIQGSDAGWTLGYMLNLTNMIPAEQPLSTPLSHSTYVFL MVLFSLVLFTVAIIGLLIFHKPSYFWKDMV Click to Show/Hide
|
|||||
| Family | GDA1/CD39 NTPase family |
|||||
| Function |
FUNCTION: Catalyzes the hydrolysis of both di- and triphosphate nucleotides (NDPs and NTPs) and hydrolyze NTPs to nucleotide monophosphates (NMPs) in two distinct successive phosphate-releasing steps, with NDPs as intermediates and participates in the regulation of extracellular levels of nucleotides (Probable) (PubMed:8529670, PubMed:8626624, PubMed:8955160, PubMed:8996251). By hydrolyzing proinflammatory ATP and platelet-activating ADP to AMP, it blocks platelet aggregation and supports blood flow (PubMed:8955160, PubMed:8996251). {ECO:0000269|PubMed:8529670, ECO:0000269|PubMed:8626624, ECO:0000269|PubMed:8955160, ECO:0000269|PubMed:8996251, ECO:0000305|PubMed:10636909}.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
F1
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
f1-SMCC-DM1 |
Mertansine DM1 |
Undisclosed |
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[1] |
F314
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
f314-MC-VC-PAB-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[1] | |
f314-MC-MMAF |
Undisclosed |
Undisclosed |
Undisclosed |
[1] | |
f314-SMCC-DM1 |
Mertansine DM1 |
Undisclosed |
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[1] | |
f314-SPDB-DM4 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] | |
f314-C4-VC-PAB-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
C4-VC-PAB |
[1] | |
f314-C5-VC-PAB-MMAE-0.8 |
Monomethyl auristatin E |
Microtubule (MT) |
C5-VC-PAB |
[1] | |
f314-C5-VC-PAB-MMAE-1.8 |
Monomethyl auristatin E |
Microtubule (MT) |
C5-VC-PAB |
[1] | |
f314-C5-VC-PAB-MMAE-2.3 |
Monomethyl auristatin E |
Microtubule (MT) |
C5-VC-PAB |
[1] | |
f314-C5-VC-PAB-MMAE-3.0 |
Monomethyl auristatin E |
Microtubule (MT) |
C5-VC-PAB |
[1] | |
f314-C6-VC-PAB-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
C6-VC-PAB |
[1] |
